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An Inhibitory Role for FAK in Regulating Proliferation: A Link Between Limited
Adhesion and RhoA-ROCK Signaling
Abstract
Focal adhesion kinase (FAK) transduces cell adhesion to the extracellular matrix into proliferative signals.
We show that FAK overexpression induced proliferation in endothelial cells, which are normally growth
arrested by limited adhesion. Interestingly, displacement of FAK from adhesions by using a FAK−/− cell
line or by expressing the C-terminal fragment FRNK also caused an escape of adhesion-regulated growth
arrest, suggesting dual positive and negative roles for FAK in growth regulation. Expressing kinase-dead
FAK-Y397F in FAK−/− cells prevented uncontrolled growth, demonstrating the antiproliferative function of
inactive FAK. Unlike FAK overexpression–induced growth, loss of growth control in FAK−/− or FRNKexpressing cells increased RhoA activity, cytoskeletal tension, and focal adhesion formation. ROCK
inhibition rescued adhesion-dependent growth control in these cells, and expression of constitutively
active RhoA or ROCK dysregulated growth. These findings demonstrate the ability of FAK to suppress and
promote growth, and underscore the importance of multiple mechanisms, even from one molecule, to
control cell proliferation.
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F

ocal adhesion kinase (FAK) transduces cell adhesion
to the extracellular matrix into proliferative signals.
We show that FAK overexpression induced proliferation in endothelial cells, which are normally growth
arrested by limited adhesion. Interestingly, displacement of FAK from adhesions by using a FAK−/− cell
line or by expressing the C-terminal fragment FRNK also
caused an escape of adhesion-regulated growth arrest,
suggesting dual positive and negative roles for FAK in
growth regulation. Expressing kinase-dead FAK-Y397F
in FAK−/− cells prevented uncontrolled growth, dem-

onstrating the antiproliferative function of inactive FAK.
Unlike FAK overexpression–induced growth, loss of
growth control in FAK−/− or FRNK-expressing cells
increased RhoA activity, cytoskeletal tension, and focal
adhesion formation. ROCK inhibition rescued adhesiondependent growth control in these cells, and expression of
constitutively active RhoA or ROCK dysregulated growth.
These ﬁndings demonstrate the ability of FAK to suppress
and promote growth, and underscore the importance of
multiple mechanisms, even from one molecule, to control
cell proliferation.

Introduction
Cell proliferation in the multicellular organism is tightly controlled through the cooperative efforts of numerous microenvironmental cues, including soluble growth factors and adhesion
to the ECM. One potential point of integration between growth
factor and adhesive signaling is in the focal adhesion (Schwartz
and Ginsberg, 2002). Focal adhesions are structures that arise
during the binding and clustering of integrins and serve to physically link the actin cytoskeleton to the underlying ECM.
Because they also contain numerous growth factor receptors
and signaling proteins, focal adhesions have been proposed as
localized sites where growth factor and adhesion signaling converge (for reviews see Schwartz and Ingber, 1994; Sastry and
Horwitz, 1996). FAK is a key effector in focal adhesion signaling and a potential integrator of integrin- and growth factor–
mediated proliferative signaling. It is rapidly phosphorylated
after integrin ligation (Guan et al., 1991; Burridge et al., 1992;
Kornberg et al., 1992), which stimulates its kinase activity
Correspondence to Christopher S. Chen: chrischen@seas.upenn.edu
Abbreviations used in this paper: EC, endothelial cell; FAT, focal adhesion targeting; GAP, GTPase-activating protein; GAPDH, glyceraldehyde-3phosphate dehydrogenase; mPAD, microfabricated post array detector; PDMS,
poly(dimethylsiloxane).
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(Guan and Shalloway, 1992; Lipfert et al., 1992) and triggers
the activation of signaling pathways involved in modulating
focal adhesions and their surrounding cytoskeletal structures
(Parsons et al., 2000; Geiger et al., 2001).
Given its central role in adhesion signaling, it is not surprising that numerous studies have demonstrated a regulatory
role for FAK in cell cycle progression (Gilmore and Romer,
1996; Zhao et al., 1998; Oktay et al., 1999). Such studies have
shown that FAK overexpression drives G1/S phase cell cycle
progression, whereas dominant–negative FAK mutants, such as
FRNK, or anti-FAK antibodies block the cell cycle at the G1/S
phase boundary (Gilmore and Romer, 1996; Zhao et al., 1998;
Nolan et al., 1999; Oktay et al., 1999). Mechanistically, FAK
overexpression appears to enhance the transcriptional activation of cyclin D1 (Zhao et al., 1998). FAK appears to regulate the G1 cell cycle machinery through numerous signaling
pathways. In endothelial cells (EC), FAK is required for sustained ERK activity downstream of VEGF stimulation (Hood
et al., 2003). Additionally, FAK regulates the activity of the
Rho GTPase RhoA, which is also required for sustained ERK
signaling (Danen et al., 2000; Ren et al., 2000; Welsh et al.,
2001). Importantly, although FAK signaling clearly modulates
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Figure 1. FAK regulates adhesion-mediated
proliferation. (A–D) Graph of the percentage
of ECs in S phase, measured by the incorporation of BrdU (A), immunoﬂuorescence images
of vinculin (B and C), and a graph of the average focal adhesion area per cell (D) in cells
cultured for 24 h in 5 or 0.01% serum, on surfaces coated with 25 μg/ml ﬁbronectin. (E–H)
Graph of the percentage of ECs in S phase (E),
immunoﬂuorescence images of vinculin
(F and G), and graph of average focal adhesion
area per cell (H) in cells cultured in 5% serum
on surfaces coated with 25, 0.5, or 0.1 μg/ml
ﬁbronectin. (I–K) Graph of the percentage of
GFP- or FAK-overexpressing ECs that enter S
phase when cultured on 25 μg/ml ﬁbronectincoated surfaces in 5% serum (I), on 25 μg/ml
ﬁbronectin-coated surfaces in 0.01% serum (J),
or on 0.1 μg/ml ﬁbronectin-coated surfaces in
5% serum (K). (L) Average area of cells when
cultured in 5% serum and on surfaces coated
with 25, 0.5, or 0.1 μg/ml ﬁbronectin. Data
is expressed ± SEM for three independent
experiments. *, P < 0.05. Bar, 20 μm.
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sion, how FAK functions to regulate proliferation under different adhesive contexts is ill defined.
By examining the proliferative effects of modulating FAK
in different adhesive contexts, we have found that FAK plays
a dual role in regulating growth. In contexts of high adhesion,
FAK activity and proliferation are high. In low ECM ligand or
low cell-spreading contexts, normally growth-arrested cells can
be induced to proliferate by activating FAK. Surprisingly, the
growth inhibition in these low adhesive states is mediated by
inactive FAK, as loss of FAK in either FAK−/− cells or FRNKexpressing cells dysregulated adhesion-dependent growth control.
Full-length, kinase-dead FAK-Y397F, in contrast to FRNK,
rescued adhesion-dependent growth regulation, suggesting the
possibility that the N terminus of FAK may mediate the growth
inhibitory function. The uncontrolled growth after loss of FAK
was mediated through an increase in RhoA signaling and cytoskeletal tension. Thus, FAK appears to transduce both high
adhesive signals, to stimulate proliferation, and low adhesive
signals, to arrest growth. This dual nature highlights FAK as a
central control point for growth regulation, and underscores its
critical role in integrating the multiple adhesive, mechanical,
and biochemical functions of focal adhesions.

Results
FAK regulates adhesion-mediated
proliferation

To begin to explore the role of FAK in regulating proliferation,
we first established the dependence of bovine pulmonary artery
EC proliferation on growth factors and adhesion. Cells were
G0 synchronized at confluence, replated under various growth
factor or adhesive conditions, and assayed for proliferation by
tracking BrdU incorporation as a marker of S phase entry. As
expected, when ECs were exposed to low serum (0.01%) or
grown on surfaces coated with a low density of fibronectin
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cell cycle progression, it does not appear to be required, as
FAK−/− cells and cells treated with FAK RNAi still proliferate (Ilic et al., 1995; Duxbury et al., 2003). Thus, the role of
FAK in adhesion-regulated proliferation is likely to be multifaceted, and may depend on the adhesive context in which FAK
signaling occurs.
To conceptually dissect how FAK might regulate adhesiondependent proliferation, it is necessary to define adhesion
more precisely. Although cell adhesion is initiated by integrin
binding to ECM ligands, it involves numerous other processes,
such as integrin clustering, focal adhesion maturation, and cell
spreading and flattening against the substrate, each of which appears to be involved in regulating proliferation. Integrin ligation
and clustering, although necessary for the proliferation of adherent cells, is not sufficient to support cell cycle progression.
Proliferation also requires that the ECM allows cells to physically spread against the substrate; cells that are prevented from
spreading or flattening against the ECM are growth arrested
(Chen et al., 1997). Interestingly, these changes in cell spreading appear to be required for RhoA-mediated cytoskeletal tension and focal adhesions to develop (Chen et al., 2003; Tan
et al., 2003), and inhibiting cytoskeletal tension and focal adhesion formation appear to abolish proliferation in spread cells
(Bohmer et al., 1996; Huang et al., 1998). Thus, changes in integrin ligation, cell spreading, cytoskeletal tension, and focal
adhesion formation are clearly interdependent, and have all
been implicated in growth regulation. Because of the prominent
role of FAK in multiple aspects of the adhesive processes, including focal adhesion development (Lewis and Schwartz,
1995), spreading (Gilmore and Romer, 1996; Richardson et al.,
1997), and mechanical tension (Burridge and ChrzanowskaWodnicka, 1996), FAK may serve as a critical point of integration for transducing each of these adhesive processes into a
coordinated biological response, such as proliferation. However,
despite the involvement of FAK in the various aspects of adhe-

These data suggested the possibility that FAK signaling may
be fundamentally different in spread versus unspread cells and
that FAK may be directly involved in the proliferation response
of cells to changes in cell spreading.
To explore this possibility, cells were transduced with
wild-type FAK adenovirus and cultured on the micropatterned
substrates. FAK overexpression increased proliferation as compared with a GFP control (Fig. 2 H). Because FAK overexpression appears to rescue proliferation that was inhibited both by
low-density fibronectin and by reduced cell spreading, but not
by low serum, FAK appears to be specifically involved in proliferative signals mediated by adhesive cues. In physiologic
settings, however, the primary mode of adhesion-mediated
arrest in ECs is mediated by confluence of the monolayer, not
through changes in ligand density or cell area. To test whether
FAK signaling is involved in confluence-induced arrest, we
expressed FAK in monolayer cultures. FAK overexpression
increased proliferation in cells arrested by traditional contact
inhibition (Fig. 2 I). Together these studies suggest that FAK
may be involved in several of the means by which adhesion
regulates proliferation.
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(0.1 μg/ml), cell proliferation was inhibited compared with
cells grown in high serum (5%) or on surfaces coated with a
high density of fibronectin (25 μg/ml; Fig. 1, A and E). To examine whether the serum or fibronectin concentrations affected
focal adhesion formation, we analyzed vinculin distribution
by immunofluorescence. Whereas cells grown in high serum
formed large, well-defined focal adhesions (Fig. 1 B), cells cultured in low serum showed reduced focal adhesion number and
area (Fig. 1, C and D). Fibronectin concentration affected focal
adhesion formation to an even greater extent (Fig. 1, F–H). This
correlation between proliferation and focal adhesion area in
both serum- and adhesion-regulated growth suggested the possibility that FAK might be involved in both growth factor– and
adhesion-mediated proliferation. To begin to explore this possibility, we examined whether overexpression of FAK could overcome the proliferation block caused by either low serum or
low-density fibronectin. G0-synchronized ECs were transduced
with a recombinant adenovirus containing wild-type FAK, resulting in FAK overexpression and constitutive autophosphorylation. FAK overexpression did not rescue the growth arrest
caused by low serum and did not affect proliferation induced by
high serum (Fig. 1, I and J). In contrast, cells plated on lowdensity fibronectin dramatically increased proliferation upon
FAK overexpression (Fig. 1 K). These findings suggest the possibility that FAK mediates the proliferative signals initiated by
adhesion, but not by growth factors.
Cell adhesion involves many different steps, including
integrin ligation and clustering and cell spreading and flattening against the substrate (Chen et al., 1997). Decreasing fibronectin density not only decreased integrin clustering and focal
adhesion formation, but also impaired cell spreading (Fig. 1 L).
Because changes in cell spreading can directly regulate cell
proliferation, despite the presence of excess extracellular
matrix, we examined whether FAK is also involved in the regulation of cell proliferation by changes in cell shape. To specifically modulate cell shape without altering fibronectin density
and integrin clustering, we used microcontact printing to generate micrometer-scale islands coated with a high density of
fibronectin, separated by nonadhesive regions such that the
size of the islands dictated the degree of cell spreading. ECs
seeded onto small, square islands (625 μm2) remained relatively unspread, whereas ECs seeded onto uniformly coated
surfaces spread to an average of 2,000 μm2 (Fig. 2, A and B).
Measurement of S phase entry under these conditions demonstrated that the unspread cells could not proliferate (Fig.
2 C). Substantially fewer and smaller focal adhesions formed
in the growth-arrested unspread cells compared with spread
controls (Fig. 2, D–F), suggesting the possibility that alterations in focal adhesion architecture and/or signaling may also
underlie proliferative regulation by cell spreading. To examine
whether cell spreading specifically affected FAK activity, we
measured FAK phosphorylation at tyrosine 397 in these cells.
At early time points after replating, attachment, spreading,
and FAK phosphorylation at Y397 was similar between spread
and unspread cells (Fig. 2 G). At later time points, unspread
cells showed progressively lower FAK phosphorylation while
spread cells transiently increased FAK activation (Fig. 2 G).

Figure 2. FAK regulates shape-mediated proliferation. (A and B) F-actin
(red) and DAPI (blue) stain of ECs cultured on surfaces uniformly coated
with 25 μg/ml ﬁbronectin (Spread; A) or onto 625-μm2 islands of ﬁbronectin (Unspread; B). (C) Graph of the percentage of spread versus unspread cells in S phase measured by the incorporation of BrdU. (D and E)
Immunoﬂuorescence images of vinculin in cells cultured on surfaces uniformly coated with 25 μg/ml ﬁbronectin (D) or onto 625-μm2 islands of
ﬁbronectin (E). (F) Graph of the average focal adhesion area per spread
versus unspread cell. (G) Western blot of phospho–Y397-FAK and total
FAK in spread (S) versus unspread (U) cells at 30, 60, 90, 180, and 360 min
after replating, and a graph showing phospho-FAK normalized to total
FAK. (H and I) Graph of the percentage of GFP- or FAK-overexpressing ECs
that enter S phase when cultured on 625-μm2 islands of ﬁbronectin (H) or
in a monolayer (I). Data is expressed ± SEM for three independent
experiments. *, P < 0.05. Bar, 20 μm.
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Loss of FAK signaling causes constitutive
cell proliferation

Figure 3. FAK has a growth inhibitory role. (A and B) F-actin stain (A) and graph of the percentage of cells in S phase (B) for FAK−/− cells and FAKreexpressing cells cultured on different-sized islands of ﬁbronectin. (C) Western blot of phospho–Y397-FAK and total FAK in FAK−/− and FAK-reexpressing
cells in spread (substrates coated with 25 μg/ml ﬁbronectin; S) or unspread (substrates patterned with 625-μm2 islands of ﬁbronectin; U) conditions.
(D) Graph of the percentage of FAK−/− and FAK-reexpressing cells in S phase when cultured in a 3D collagen gel. All data is expressed as ± SEM for
three independent experiments. *, P < 0.05 between FAK−/− or FAK-reexpressing cells. Bar, 10 μm.
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The stimulation of proliferation by FAK overexpression suggests
at least two possible models for adhesion-regulated proliferation.
The first, and predominantly accepted, model is that FAK
activity triggered by adhesion stimulates proliferation (Gilmore
and Romer, 1996; Zhao et al., 1998). A second, equally plausible model is that inactive FAK in cells with limited adhesion or
spreading inhibits proliferation. To begin to address these possibilities, we examined the proliferative response of cells completely lacking FAK. G0-synchronized FAK−/− mouse embryo
fibroblasts were seeded onto micropatterned islands of various
sizes or onto unpatterned surfaces, where the cells ranged in
size from 625 μm2 to fully spread (2,500 μm2; Fig. 3 A).
Well-spread FAK−/− cells proliferated maximally, as expected
(Fig. 3 B). Surprisingly, unspread FAK−/− cells also proliferated (Fig. 3 B), indicating that loss of FAK may have eliminated
adhesion-dependent proliferative control mechanisms. To address
this, we examined the effect of reexpressing FAK on proliferation.
FAK reexpression to endogenous levels, which resulted in
the rescue of the spreading-dependent FAK autophosphorylation
seen in ECs (Fig. 3 C), inhibited proliferation only in unspread
cells, rescued normal adhesion-dependent growth control, and
confirmed that the loss of growth control was specific to loss
of FAK (Fig. 3 B). The constitutive proliferation in FAK−/−
cells suggests that one important and previously undescribed
function of FAK is to limit proliferation in low adhesive conditions. However, although the micropatterned substrates provide
a precise quantitative method to control adhesion, fibroblasts
are typically adhesion-regulated in a 3D microenvironment.

In this context, we cultured the FAK−/− and FAK-reexpressing
fibroblasts in 3D collagen gels, where cell proliferation is
often suppressed. Consistent with the micropatterning studies,
FAK−/− cells continued to proliferate at higher levels in the
collagen gel, whereas FAK reexpression rescued growth suppression (Fig. 3 D). As with ECs, highly overexpressing FAK to
severalfold above endogenous levels in the FAK-reexpressing
fibroblasts increased proliferation in unspread conditions
(unpublished data). Thus, it appears that a delicate balance of
FAK expression is needed for proliferative control.
Because the FAK−/− and FAK-reexpressing cell lines
are immortalized, and known compensatory changes in signaling pathways might have affected our interpretation of the
proliferative effect, we next examined whether the same inhibitory role of FAK in proliferation might operate in normal
nonimmortalized cells. To address this question, we generated
recombinant adenoviruses to express the well-characterized
dominant–negative FAK construct FRNK; consisting of amino
acids 668–1,053 of wild-type FAK (Schaller et al., 1993),
as well as a shorter C-terminal construct of FAK containing only the focal adhesion–targeting (FAT) domain (amino
acids 919–1,053; Prutzman et al., 2004). We also generated an
autophosphorylation-defective FAK mutant (FAK-Y397F) in
adenovirus (Schaller et al., 1994). Infecting cells with the FAK
adenovirus causes overexpression of FAK that is highly phosphorylated (Fig. 4 A), whereas expression of FRNK, FAT, and
FAK-Y397F down-regulates endogenous FAK phosphorylation
(Fig. 4 A). Previous studies have shown that FRNK and FAT
displace endogenous FAK from adhesions (Richardson and
Parsons, 1996). We have confirmed these findings in our system.

studies (Gilmore and Romer, 1996; Zhao et al., 1998), the loss of
adhesion-dependent proliferative control in FAK−/−, FRNK-,
or FAT-expressing cells suggests that, in addition, inactive
FAK might function to actively inhibit proliferation. FRNK and
FAT may relieve this inhibition by displacing inactive FAK from
the adhesion, whereas FAK phosphorylation might do so via a
different mechanism. In support of this hypothesis, overexpressing the inactive FAK-Y397F in FAK−/− cells, like wild-type
FAK, rescued adhesion-mediated growth control (Fig. 4 E).
Together, these results uncover a previously undescribed function of FAK as a negative growth regulator, and, in particular,
support a model whereby inactive FAK within adhesions
inhibits proliferation.
As an initial characterization of the proliferative mechanisms induced by FAK or FRNK, we examined the role of
downstream MAPK and Src signaling pathways. Although most
extracellular signals regulate proliferation through the regulation of MAPK-dependent signals in the G1 phase of the cell cycle,
others have been reported to occur at different levels (Brooks
et al., 1997). Because FAK is known to have a very close association with the nonreceptor tyrosine kinase Src, which is
another important proliferative signaling protein, we also examined whether FAK- or FRNK-induced proliferation were
Src dependent. G0-synchronized cells were transduced with
adenoviruses to express FAK, FRNK, or GFP, seeded onto
625-μm2 islands of fibronectin, and treated with 10 μM of the
MEK inhibitor UO126, 25 μM JNK inhibitor I, 1 μM of the
p38 inhibitor SB203580, or 1 μM of the Src inhibitor PP2.
Although inhibiting MEK or JNK activity completely blocked

Downloaded from www.jcb.org on November 27, 2006

Cells expressing GFP, FRNK, FAK, and FAK-Y397F were fractionated into Triton X-100–soluble and –insoluble pools and
blotted for FAK. FRNK decreased total FAK in the insoluble pool
and phosphorylated FAK to nearly undetectable levels (Fig. 4 B).
Similarly, FRNK expression also decreased the amount of
total FAK (and phosphorylated FAK) that coimmunoprecipitated with paxillin (unpublished data). Because FRNK, FAT,
and FAK-Y397F all contain the C-terminal FAT region, lack
kinase activity, compete to displace endogenous full-length
FAK from the focal adhesion, and thereby decrease endogenous
FAK phosphorylation, we postulated that expression of these
dominant–negative mutants might have the same proliferative
effects as seen in the FAK−/− cells. To examine this possibility, ECs were transduced with recombinant adenoviruses to
express FRNK, FAT, or FAK-Y397F, cultured on small islands
of fibronectin, and assayed for proliferation by BrdU incorporation. As compared with GFP and FAK, as negative and positive
controls, respectively, FRNK increased proliferation (Fig. 4 C).
Expressing the FAT construct also relieved the proliferation arrest induced by restricted adhesion. Interestingly, FAK-Y397F
did not induce cell proliferation. FAK or FRNK expression
also released cells from growth arrest in monolayer cultures, but
did not rescue proliferation in cells placed in suspension
(unpublished data). Although the various FAK constructs increased proliferation relative to a GFP control in conditions of
low adhesion, cell proliferation in a highly adhesive environment
was not dramatically affected by expression of the FAK constructs (Fig. 4 D). Although the stimulatory effects of wild-type
FAK expression on proliferation is consistent with previous

Figure 4. FRNK stimulates proliferation in low adhesive contexts. (A) Western blots of GFP-, FAK-, FRNK-, or FAK-Y397F-overexpressing ECs in spread
(substrates coated with 25 μg/ml ﬁbronectin) or unspread (substrates patterned with 625-μm2 islands of ﬁbronectin) conditions and probed for phospho–
Y397-FAK, total FAK, or GAPDH. (B) Western blot of phospho–Y397-FAK and total FAK in the Triton X-100–insoluble fraction of unspread ECs expressing
GFP (control), FRNK, FAK, or FAK-Y397F. β–actin is shown as a loading control. (C and D) Graph of the percentage of GFP-, FAK-, FRNK-, FAT-, or FAKY397F–overexpressing ECs entering S phase when cultured on 625-μm2 islands of ﬁbronectin (C) or on substrates coated with 25 μg/ml ﬁbronectin (D).
(E) Graph of the percentage of FAK−/− cells, FAK-reexpressing cells, and FAK−/− cells overexpressing FAK-Y397F in S phase when cultured in spread
or unspread conditions. (F) Graph of the percentage of GFP-, FAK-, or FRNK-overexpressing ECs entering S phase when cultured on 625-μm2 islands of
ﬁbronectin and treated with either 10 μM UO126 or 1 μM PP2. All data is expressed as ± SEM for three independent experiments. *, P < 0.05 with GFP
control or FAK−/− cells. #, P < 0.05 with untreated control.
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FAK- and FRNK-induced proliferation, the p38 inhibitor had
no effect (Fig. 4 F and not depicted). Interestingly, FAK- and
FRNK-expressing cells responded differently to PP2 treatment.
The FAK-mediated increase in cell proliferation was blocked by
inhibiting Src, but FRNK-mediated proliferation was not (Fig.
4 F). These findings suggest a divergence of signaling pathways
between the proliferative effects mediated by FAK activation
and those mediated by loss of FAK. Because the dysregulation
of adhesion-dependent growth control by FAK down-regulation
has not been previously described, we chose to further investigate the molecular mechanisms underlying this process.
FAK regulates proliferation through RhoA

FAK regulates proliferation through RhoAmediated changes in cytoskeletal tension

To determine whether changes in RhoA signaling are sufficient
to directly affect proliferation, we overexpressed a constitu282
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Our initial studies indicated that focal adhesions are significantly
larger in conditions that promoted proliferation than in those
that arrested growth. Therefore, we explored whether the size of
focal adhesions in spread and unspread cells was also affected by
the expression of FAK, FRNK, FAT, and FAK-Y397F. FRNK and
FAT expression both dramatically increased focal adhesion area
in unspread cells, but not in well-spread cells (Fig. 5, A and B),
mirroring their effects on proliferation. FAK and the Y397F
mutant increased focal adhesion size, but to a lesser extent. Focal
adhesion size has been shown to depend on RhoA signaling
(Ridley and Hall, 1992; Nobes and Hall, 1995), suggesting
that changes in FAK signaling may modulate RhoA activity.
To test this possibility, we examined RhoA activity in FRNK-,
FAK-, or FAK-Y397F–expressing ECs. Cells were transduced
with recombinant adenoviruses, replated onto 625-μm2 square
patterns or onto surfaces uniformly coated with fibronectin,
and lysed 6 h after replating. Using the RhoA pull-down assay
to measure GTP-bound RhoA, we found that FRNK expression increased RhoA activity compared with GFP-expressing
control cells both in spread and unspread conditions, whereas
FAK or FAK-Y397F expression had little to no effect (Fig. 6 A).
Likewise, the FAK−/− cells showed higher RhoA activity
than FAK-reexpressing cells (Fig. 6 B). To address whether
RhoA was directly involved in the dysregulation of proliferative
control induced by loss of FAK signaling, we examined the effects of inhibiting the RhoA effector ROCK in FRNK-expressing
cells. ROCK inhibition with 50 μM Y-27632 blocked the
FRNK-induced increase in proliferation in unspread cells (Fig.
6 C). This effect was specific to the release of growth inhibition
by FRNK, as Y-27632 treatment did not inhibit proliferation
rates in well-spread cells (Fig. 6 D). Similarly, FAK−/− cells
treated with Y-27632 also regained adhesion-dependent growth
control. That is, cell proliferation was low in unspread cells
and high in spread cells in the presence of the ROCK inhibitor
(Fig. 6, E and F). Collectively, these data suggest a signaling pathway whereby lack of FAK or displacing endogenous FAK from
focal adhesions causes an increase in RhoA activity, and this
increase, in turn, is required for loss of the growth control normally observed in low adhesive conditions.

Figure 5. FRNK and FAT induce focal adhesion growth in unspread cells.
(A) Immunoﬂuorescence images of vinculin in GFP-, FAK-, FRNK-, FAT-, or
FAK-Y397F–overexpressing ECs cultured for 24 h onto 625-μm2 islands of
ﬁbronectin (Unspread) or surfaces uniformly coated with 25 μg/ml ﬁbronectin (Spread). Graph of the average focal adhesion area of GFP-, FAK-,
FRNK-, FAT-, or FAK-Y397F–expressing ECs when cultured in spread versus
unspread conditions (B). Data is expressed ± SEM. Approximately 150
cells were analyzed in each condition; *, P < 0.05 with GFP control;
#, P < 0.05 as compared with FRNK or FAT conditions. Bar, 10 μm.

tively active form of RhoA (RhoA-V14) in unspread ECs.
RhoA-V14 dramatically increased stress fiber formation
(Fig. 7 A) and was sufficient to overcome the spreading-regulated

Discussion

Figure 6. FRNK expression increases RhoA activity. (A) RhoA-GTP and
total RhoA levels in GFP-, FRNK-, FAK-, or FAK-Y397F–expressing ECs.
(B) RhoA-GTP and total RhoA levels in FAK−/− or FAK-reexpressing cells.
(C and D) Graph of the percentage of GFP- or FRNK-overexpressing ECs
that enter S phase when cultured on 625-μm2 islands of ﬁbronectin (C)
or on surfaces coated with 25 μg/ml ﬁbronectin (D) and either untreated
or treated with 50 μM Y-27632. (E and F) Graph of the percentage of
FAK−/− or FAK-reexpressing cells that enter S phase when cultured on
625-μm2 islands of ﬁbronectin (E), or on surfaces coated with 25 μg/ml
ﬁbronectin (F) and either untreated or treated with 50 μM Y-27632. Data
is expressed ± SEM for three independent experiments. +, P < 0.08 compared with control; ++, P < 0.06 compared with control; *, P < 0.05
between FRNK-overexpressing condition versus GFP control, or FAK−/−
versus FAK-reexpressing cells; #, P < 0.05 between FRNK-induced proliferation or FAK−/− proliferation in untreated versus drug-treated samples.

block in proliferation (Fig. 7 B). High RhoA also released cells
from proliferation arrest induced by confluence (unpublished
data). This effect was mediated through the RhoA effector
ROCK, as treatment with Y-27632 abrogated the RhoA-V14–

In this study, we demonstrate that FAK plays a key role in the
regulation of proliferation by cell adhesion, whether modulated
by ECM density, cell spreading, confluence, or 3D culture. FAK
overexpression has been shown to increase proliferation in previous studies (Gilmore and Romer, 1996; Zhao et al., 1998). We
find that FAK exerts not only stimulatory but also inhibitory effects on proliferation. The inhibitory function of FAK is lost
in FAK−/− cells and, importantly, rescued when FAK is
reexpressed. Interestingly, expressing the C-terminal fragments
of FAK (FRNK or FAT) also dysregulated the inhibitory function of FAK, whereas the full-length, kinase-dead mutant (FAKY397F) could rescue growth inhibition. These data suggest that
the inhibitory function of FAK lies in its N-terminal domain.
Given that we and others find that FRNK and FAT displace
endogenous full-length FAK from focal adhesions (Richardson
and Parsons, 1996), these C-terminal constructs might interfere
with FAK function by competitively inhibiting the targeting of
cellular FAK to the focal adhesion, suggesting the interesting
possibility that a pool of inactive FAK may normally function to
inhibit proliferation through these interactions, and suggests
a model whereby FAK acts within adhesions as a graded sensor
that transduces adhesive signals to regulate the cell cycle (Fig. 8).
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induced proliferation (Fig. 7 B). This ROCK activity was not
only necessary but also sufficient to induce proliferation, as expression of a constitutively active ROCK (ROCK-∆3) also bypassed the shape-dependent control mechanism (Fig. 7 D). As
with RhoA-V14 overexpression, ROCK-∆3 overexpression had
no effect in well-spread cells (Fig. 7, C and E).
One important consequence of RhoA and ROCK signaling is in mediating changes in myosin-regulated cytoskeletal
tension (Amano et al., 1996; Kimura et al., 1996; Ishizaki et al.,
1997). To address whether FRNK-induced signaling altered
focal adhesion structure and proliferation via RhoA-mediated
changes in cytoskeletal tension, we assessed myosin phosphorylation in cells expressing FRNK. FRNK expression dramatically
increased the amount of phosphomyosin compared with GFP
controls (Fig. 7 F). Although this suggests that FRNK might be
functioning to increase cytoskeletal tension in unspread cells,
myosin phosphorylation is not always associated with the development of tension. To directly measure the tension transmitted across the focal adhesion onto the underlying substrate, we
used a previously described microfabricated force sensor (Tan
et al., 2003), consisting of an array of vertically placed elastomeric microneedles. These microneedles report the traction
force exerted by cells on the underlying substrate. Thus, we
directly measured the tension generated in unspread cells expressing FAK, FRNK, FAK-Y397F, or a GFP control. Notably,
only FRNK expression increased traction force (Fig. 7, G and H).
FAK expression showed no differences in tension, whereas expression of FAK-Y397F decreased tension. Collectively, these
data support a novel role for FAK in growth control, in which
loss of FAK signaling can induce RhoA-mediated cytoskeletal
tension, leading to the loss of adhesion-dependent control of
cell proliferation.
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Figure 7. RhoA-mediated contractility rescues proliferation in unspread
cells. (A) F-actin stain of GFP-, or RhoA-V14–overexpressing ECs cultured
on 625-μm2 islands of ﬁbronectin. (B and C) Graph of the percentage of
GFP- or RhoA-V14–overexpressing ECs that enter S phase when cultured
on 625-μm2 islands of ﬁbronectin (B), or on surfaces uniformly coated with
25 μg/ml ﬁbronectin (C) and either untreated or treated with 50 μM
Y-27632. (D and E) Graph of the percentage of GFP- or ROCK-∆3–overexpressing ECs that enter S phase when cultured on 625-μm2 islands of
ﬁbronectin (D), or on surfaces that were uniformly coated with 25 μg/ml
ﬁbronectin (E), and either untreated or treated with 50 μM Y-27632.
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(F) Western blot and graph of phosphorylated myosin light chain in GFPversus FRNK-expressing ECs, normalized to GAPDH. (G) A representative
GFP-expressing EC cultured on the mPAD force sensors (red, ﬁbronectin;
green, GFP; blue, nucleus) and accompanying vector plot (green arrows
indicate magnitude and the direction of force exerted on each underlying
post). (H) Distribution plot of the magnitude of traction forces exerted by
GFP-, FAK-, FRNK-, or FAK-Y397F–expressing ECs on mPADs. Data is expressed ± SEM for at least three independent experiments for proliferation
and myosin phosphorylation data. For proliferation graphs, * denotes P <
0.05 between RhoA-V14 or ROCK-∆3 versus GFP control and # denotes
P < 0.05 between RhoA-V14 or ROCK-∆3–induced proliferation in untreated versus drug-treated samples. For force distribution plot, * denotes
P < 0.05 between adenovirus condition as compared with GFP control.
Bars, 10 μm.
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High FAK activation caused by high adhesion or by high
FAK expression stimulates proliferation, whereas minimal
adhesion prevents FAK activation and yields inactive complexes that inhibit proliferation. Interestingly, Moissoglu and
Gelman (2003) observed an unexpected enhancement of soft
agar colony formation in v-Src–transformed cells lacking FAK
that was subsequently prevented by FAK reexpression, suggesting
the possibility that FAK may play a negative regulatory role
in transformation. Notably, this occurred in a low adhesive
environment. An alternative model for the proliferative response
to both up- and down-regulation of FAK is the possibility that
dynamic cycling of FAK activation and deactivation is required
for growth inhibition. Repeated cycles of FAK phosphorylation
and dephosphorylation appear to be important for cell migration, as both decreasing and increasing FAK activity reduce
migration (Yu et al., 1998; Angers-Loustau et al., 1999). Thus,
both stimulatory and inhibitory roles for FAK may be an inherent feature of its function in numerous cellular processes.
RhoA is a critical regulator of focal adhesion formation
(Ridley and Hall, 1992; Nobes and Hall, 1995). Our results also
demonstrate that RhoA plays a role in the dysregulation of
growth control in cells lacking FAK. Both FRNK-expressing
cells and FAK−/− cells exhibit high RhoA activity that appears
to be both necessary and sufficient for the observed proliferative
effect (Fig. 8), supporting studies suggesting that RhoA promotes cell cycle progression (Olson et al., 1998). Although we
show that the RhoA effector ROCK is important in our system,
RhoA-mediated mDia signaling also appears to be sufficient to
induce proliferation (Mammoto et al., 2004), suggesting that
numerous RhoA signals may regulate growth. The mechanism
by which FRNK and loss of FAK might up-regulate RhoA remains to be defined, although a simple mechanism may be that
FRNK opposes the suppression of RhoA activity by endogenous FAK. The ability of FAK to down-regulate RhoA activity
is well documented (Ren et al., 2000), and it has been shown
that FAK may interact with the Rho GTPase-activating protein
(GAP) GRAF (Hildebrand et al., 1996) and phosphorylate
p190RhoGAP (Holinstat et al., 2006). It is possible that under
different adhesive contexts, such as high or low ECM ligand
density or high or low cell spreading, FAK may alter its interaction with Rho GAPs or Rho GEFs and, thus, modulate RhoA
activity and proliferation.
It has long been known that changes in cell shape and
the associated changes in cytoskeletal tension are required for

Figure 8. Model for FAK modulation of
adhesion-regulated proliferation. (1) In conditions that activate FAK (green FAK circles),
such as high adhesive contexts or FAK overexpression, FAK plays a stimulatory role in
proliferation. (2) Endogenous FAK in low
adhesive contexts, including low cell spreading, low ﬁbronectin density, and 3D gels, is
largely inactive (black FAK circles) and inhibits
proliferation. When inactive full-length FAK is
displaced by FRNK or FAT (3), or is eliminated
as in FAK−/− cells (4), RhoA is activated,
leading to ROCK activation and the development of cytoskeletal tension, creating a condition that is permissive for proliferation even in
low adhesive conditions. (5) The dominant–
negative FAK-Y397F (black FAK circles with F)
is sufﬁcient to rescue the inhibitory function of
FAK, but not its stimulatory role, in proliferation. Expression of constitutively active RhoA
or ROCK (6) alone can induce proliferation in
low adhesive contexts.

For many adherent cell types, both integrin ligation and
cell spreading are required to support proliferation. Because focal adhesion architecture and, likely, the focal adhesion character are different in spread and unspread cells, it is probable
that focal adhesions formed under these various adhesive or
mechanical contexts transmit different signals, leading to potentially divergent cellular behaviors. Importantly, FAK appears
to be a central regulator of adhesion-mediated proliferation,
whether signaled by spreading, confluence, ligand density, or
3D matrix architecture, where it can transduce both stimulatory and inhibitory proliferative signals. Understanding how
this single molecule can play such a central role in many complex interactions will uncover important insights into how cells
navigate and respond to their adhesive and mechanical environments in physiologically meaningful ways.

Downloaded from www.jcb.org on November 27, 2006

proliferation (Folkman and Moscona, 1978; Ingber, 1990; Chen
et al., 1997; Huang et al., 1998). We show that FAK transduces
cell shape into proliferative signals. Interestingly, although
FAK has been implicated as a mechanosensor where increasing
tension leads to FAK activation (Wang et al., 2001), we show
that FAK also alters the cytoskeletal tension and forces experienced at the adhesion. Expression of FRNK, through its effects
on RhoA, increases myosin-based cytoskeletal tension, confirming earlier suggestions from the Parsons group that FRNK
might increase cellular contractility (Martin et al., 2002). It has
been previously observed that FRNK also increases focal adhesion size (Giannone et al., 2002). Our findings would suggest
that these changes in focal adhesions are actually mediated by
increased cytoskeletal tension, as focal adhesion maturation is
induced by mechanical stress (Choquet et al., 1997; Balaban
et al., 2001; Riveline et al., 2001). Thus, it appears that FAK
both responds to and causes changes in mechanical force, and
the latter links changes in cell adhesion to changes in cell mechanics and proliferation. These two reciprocal functions likely
provide the mechanochemical feedback that is required for
tightly integrating the mechanical and biochemical dynamics
of cell adhesion.
The role of FAK in cell proliferation has implications for
human physiology and pathology, where FAK protein overexpression has been found in invasive human tumors (Owens
et al., 1995; Kornberg, 1998). This has led to the suggestion that
targeting FAK might reduce cancer proliferation, migration,
and invasion. However, it is now clear that the model whereby
FAK is strictly a stimulatory molecule for proliferation is oversimplified. In fact, FAK down-regulation can increase tumor cell
motility, invasion, and metastasis (Ayaki et al., 2001; Lu et al.,
2001), and we speculate that it may also extend to include increased proliferation. Thus, simply eliminating FAK function in
cancer settings may be detrimental, and recognizing these additional layers in FAK function may reveal how cells can interpret
complex adhesive contexts into a well-adapted response.

Materials and methods
Cell culture and reagents
Bovine pulmonary artery ECs (VEC Technologies, Inc.) were cultured in
low glucose DME containing 2 mM glutamine, 100 units/ml penicillin,
100 μg/ml streptomycin, and 5% bovine serum (all from Invitrogen). ECs
were maintained in a humidiﬁed 10% CO2 incubator. FAK−/− and FAKreexpressing mouse embryo ﬁbroblasts were a gift from S. Hanks (Vanderbilt
University, Nashville, TN) and were cultured in DME containing 4,500 mg
of D-glucose/ml, 2 mM glutamine, 100 units/ml penicillin, 100 μg/ml
streptomycin, 0.25 μg of amphotericin B/ml (all from Invitrogen), and
10% fetal bovine serum (Atlanta Biologicals) and were maintained at 37°C
in a humidiﬁed 5% CO2 incubator. The following reagents were purchased from the given suppliers: human ﬁbronectin (Invitrogen); Y-27632
(Calbiochem), PP2 (Calbiochem), JNK inhibitor I, UO126 (Calbiochem),
anti-vinculin clone hVin-1 (Sigma-Aldrich), TRITC-conjugated phalloidin
(Sigma-Aldrich), anti-RhoA (Santa Cruz Biotechnology, Inc.), phosphoY397-FAK antibody (BioSource International), total FAK antibody (Cell Signaling Technology), phospho-S18/S19 MLC antibody (Cell Signaling
Technology), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
antibody (Abcam).
Immunocytochemistry, image analysis, and quantitative analysis
of focal adhesions
For F-actin stains, cells were ﬁxed with 4% paraformaldehyde in PBS.
F-actin was visualized by incubating samples with ﬂuorophore-conjugated
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phalloidin (Invitrogen). Quantitative analysis of focal adhesions was performed as previously described (Nelson et al., 2004). In brief, cells were
incubated for 1 min in ice-cold cytoskeleton buffer (50 mM NaCl, 150 mM
sucrose, 3 mM MgCl2, 1 μg/ml aprotinin, 1 μg/ml leupeptin, 1 μg/ml
pepstatin, and 2 mM PMSF), followed by 1 min in cytoskeleton buffer supplemented with 0.5% Triton X-100. Detergent-extracted cells were ﬁxed in
4% paraformaldehyde in PBS, washed, and incubated with a primary antibody to vinculin (Sigma-Aldrich). After incubation with Alexa Fluor 594–
conjugated secondary antibodies (Invitrogen), quantitative microscopy of
focal adhesion proteins was performed using a charge-coupled device
camera (Orca; Hamamatsu) attached to an inverted microscope (model
TE2000; Nikon) using a 100×, 1.4 NA, oil immersion objective with a
400-ms exposure time at RT. Images were obtained and processed using
IPLab software (Scanalytics); original images were ﬁltered and binarized
to subtract background ﬂuorescence, and then segmented with a threshold
of 0.25 μm2 to quantify the area of individual adhesions. Approximately
100–150 cells were analyzed per experimental condition.

Culture and proliferation measurement of cells in collagen gel
3D collagen I gels were prepared by mixing M199 (Invitrogen), NaHCO3
(0.035% wt/vol; Sigma-Aldrich), 10 mM Hepes buffer (Invitrogen), rat tail
collagen I (BD Biosciences), and distilled water with the pH adjusted to
7.4. Synchronized FAK−/− and FAK-reexpressing cells were seeded into
a 2.4-mg/ml collagen gel at a concentration of 16,000 cells/ml followed
by gelation at 37°C for 30 min. Cells were incubated for 22 h in the presence of radiolabeled thymidine (MP Biomedicals), after which the cells
were lysed and DNA was precipitated with 16 M NaOH containing
0.25% Triton X-100. Radioactivity counts were measured using a scintillation counter (Beckman Coulter). Blank collagen gels were used to measure
background residual thymidine.
Micropatterned substrates
To generate stamps for microcontact printing of proteins, a prepolymer of
poly(dimethylsiloxane) (PDMS; Sylgard 184; Dow Corning) was poured
over a photolithographically generated master, as previously described
(Chen et al., 1997). Stamps were immersed for 1 h in 50 μg/ml ﬁbronectin,
washed three times in water, and blown dry under nitrogen. Coated
stamps were placed in conformal contact with a surface-oxidized PDMScoated glass coverslip. Stamped coverslips were immersed in 0.2%
Pluronic F127 (BASF) in PBS for 1 h and washed.
Adenovirus production
FAK, FRNK, FAT, FAK-Y397F, RhoA-V14, ROCK-∆3, and GFP recombinant
adenoviruses were constructed using the AdEasy XL system (Stratagene)
according to manufacturer’s instructions. RhoA cDNAs were obtained from
M. Philips (New York University Medical Center, New York, NY) and
P. Burbelo (Georgetown University, Washington, DC). ROCK cDNAs were
obtained from S. Narumiya (Kyoto University, Kyoto, Japan). In brief,
cDNAs were subcloned into the pShuttle-IRES-GFP1 vector, and then cotransformed with the pADEASY1 plasmid. After homologous recombination,
plasmids were used to transfect human embryonic kidney 293 cells. High
titer preparations of recombinant adenovirus were generated by CsCl2
density gradient centrifugation. In viral infection experiments, viral MOI resulting in a transduction efﬁciency of at least 80% was added to cells.
Proliferation assays
ECs were G0 synchronized by holding the cells at conﬂuence for 2 d.
FAK−/− and FAK-reexpressing cells were synchronized by 60-h serum
starvation. Cells were then trypsinized and replated in the presence of
BrdU (GE Healthcare). Cells were ﬁxed at 22 h and stained for BrdU
incorporation using a monoclonal antibody directed against BrdU (GE
Healthcare). Cells were counterstained with Hoechst 33342 (Invitrogen).
RhoA activity assays
RhoA-GTP levels were measured by pull-down assay (Ren and Schwartz,
2000). In brief, cells were washed with cold TBS, scraped into lysis buffer
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Western blots
Cells were washed in TBS and lysed in cold modiﬁed RIPA buffer (50 mM
Tris-HCl, pH 7.4, 1% Igepal CA-630, 0.25% deoxycholate, 150 mM
NaCl, 1 mM EDTA, 1 mM PMSF, 1 mM orthovanadate, 1 mM NaF, and
1 μg/ml each aprotinin, leupeptin, and pepstatin). Proteins were separated by denaturing SDS-PAGE electroblotted onto PVDF, blocked with 5%
milk in TBS, immunoblotted with speciﬁc primary antibodies, and detected
using horseradish peroxidase–conjugated secondary antibodies (Jackson
ImmunoResearch Laboratories) and SuperSignal West Dura (Pierce Chemical Co.) as a chemiluminescent substrate. Densitometric analysis was performed using a VersaDoc imaging system with QuantityOne software
(Bio-Rad Laboratories).
Microfabricated post array detectors
Microfabricated post array detectors (mPADs) were fabricated as previously described (Lemmon et al., 2005; Tan et al., 2003). mPADs used in
these studies were 11 μm tall and 3 μm in diameter, with 9 μm center–
center spacing. To control cell spreading on microneedle tips, the tips
were stamped with ﬁbronectin using microcontact printing (Tan et al.,
2003), and nonstamped regions were blocked with 0.2% Pluronic F127
(BASF). ECs expressing either GFP, FRNK, FAK, or FAK-Y397F were cultured on the mPADs for 22 h, after which the samples were ﬁxed with 4%
paraformaldehyde in PBS. Fibronectin was stained with goat anti-ﬁbronectin antibody (ICN Biomedicals) and the nuclei were stained with
Hoechst 33342. The samples were imaged using an Axiovert 200M
(Carl Zeiss MicroImaging, Inc.) with the Apotome module, equipped with
63× Plan-Apochromat, 1.4 NA, oil immersion objective, an Axiocam
camera, and Axiovision software (Carl Zeiss MicroImaging, Inc.). A Matlab program (The MathWorks) was used to obtain tractional force from
the acquired images. At least six cells were used in force measurements
in each condition.
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